The qualities of GPC1 as a potential novel biomarker for prognosis of breast cancer, especially triple-negative breast cancer, were also suggested in a recent study on exosomal proteomes (Risha et al. 2020). This evidence concerns the gene GPC1 and triple-negative breast carcinoma.